Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic P.Falciparum Malaria”

11 trials

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00646126
What this trial is testing

Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

Who this might be right for
Plasmodium FalciparumAsymptomatic ParataemiaSub Patent Parasitaemia
Tropical Medicine Research Institute
Large-scale testing (Phase 3)Study completedNCT02698748
What this trial is testing

Evaluating the Role of Chloroquine for Malaria Elimination

Who this might be right for
Malaria
Centro de Investigacao em Saude de Manhica 75
Large-scale testing (Phase 3)Study completedNCT01935882
What this trial is testing

Low Dose Primaquine for Clearance of Gametocytes

Who this might be right for
MalariaAsymptomatic MalariaPlasmodium Falciparum
London School of Hygiene and Tropical Medicine 360
Post-approval studies (Phase 4)Study completedNCT05980156
What this trial is testing

Comparing Chemoprevention Drugs for School-based Malaria Control

Who this might be right for
Malaria,FalciparumAnemia in Children
University of Maryland, Baltimore 646
Large-scale testing (Phase 3)Study completedNCT00289250
What this trial is testing

Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum

Who this might be right for
Asymptomatic P.Falciparum Malaria
London School of Hygiene and Tropical Medicine 360
Testing effectiveness (Phase 2)UnknownNCT03814616
What this trial is testing

Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections

Who this might be right for
Malaria,Falciparum
Shin Poong Pharmaceutical Co. Ltd. 300
Post-approval studies (Phase 4)Study completedNCT01256658
What this trial is testing

A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)

Who this might be right for
Malaria
Novartis 14,075
Testing effectiveness (Phase 2)Study completedNCT05974267
What this trial is testing

Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Who this might be right for
Malaria Infection
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 192
Large-scale testing (Phase 3)Ended earlyNCT01103713
What this trial is testing

Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa

Who this might be right for
Asymptomatic Parasitemia In Pregnancy
Pfizer 168
Post-approval studies (Phase 4)Study completedNCT05244954
What this trial is testing

Comparing Chemoprevention Approaches for School-based Malaria Control

Who this might be right for
Malaria,FalciparumAnemia in Children
University of Maryland, Baltimore 746
Testing effectiveness (Phase 2)Ended earlyNCT00082563
What this trial is testing

Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum

Who this might be right for
Malaria, Falciparum
Pfizer 14

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation